drugset / Trial / NCT01401179

Antibiotics Study in Preterm Premature Rupture of the Membranes

NCT01401179

Phase 3 Completed 101 enrolled Samsung Medical Center
RandomizedFactorialSingle-blindTreatment

Summary

The purpose of this study is to compare the efficacy on maternal infection, chorioamnionitis and neonatal morbidity and mortality, and to review the evidence and provide recommendations on the use of antibiotics in PPROM.

Timeline

Start
2005-04
Primary completion
2010-04
Completion
2010-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Clarithromycin Small molecule 500 mg Oral
Comparator Erythromycin Small molecule 250 mg Oral
Comparator Cefazolin Small molecule 1 g Intravenous